S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Va... by Sonsawan Sangprasert (22772538)

Study selection criteria. by Filip Stanicic (17808254)

“…</p><p>FDA-approved and off-label medications used for PTSD treatment did not yield a consistently greater CAPS decrease vs. control arms across trials. …”

PICOS criteria for the SLR. by Filip Stanicic (17808254)

“…</p><p>FDA-approved and off-label medications used for PTSD treatment did not yield a consistently greater CAPS decrease vs. control arms across trials. …”

PRISMA flow chart. by Filip Stanicic (17808254)

“…</p><p>FDA-approved and off-label medications used for PTSD treatment did not yield a consistently greater CAPS decrease vs. control arms across trials. …”

a. Positive ion mode significant difference metabolite expression difference factor analysis (A) mild PTOA group VS severe PTOA group (B) mild PTOA group VS normal group (C) Severe... by Peng-fei Han (694841)

<i>Ctsz</i>^{<i>−/−</i>} mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.... by Rachel K. Meade (22216529)

Macular regions analyzed by spectral-domain optical coherence tomography scan in the retinal thickness map analysis. by Jung-Tae Kim (8997767)

Baseline demographic characteristics. by Jung-Tae Kim (8997767)

“…Group 2 exhibited a significantly greater decrease in GCC thickness compared with Group 1(P = 0.026).…”

Flow diagram showing number of subjects included in the study population. by Jung-Tae Kim (8997767)

Capabilities expansion scenarios considered. <i><i>g</i></i>_GDP and <i><i>g</i></i>_fHE refer to the growth rate of annual GDP (in constant 2015 US$) and growt... by Margherita Molaro (17803989)

Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

Impact on different areas of health. by Margherita Molaro (17803989)

Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

The raw data used in this study. by Yu Fu (16582)

“…<div><p>Objectives</p><p>Hematological malignancies (HMs) pose a severe threat to human health and contribute substantially to the disease burden in mainland China and Taiwan. …”

Disease burden trends of leukemia and lymphoma analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

Disease burden trends of multiple myeloma and other hematological neoplasms analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

Projections of incidence for hematological malignancies in mainland China. by Yu Fu (16582)

Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China. by Yu Fu (16582)

Projections of mortality for hematological malignancies in mainland China. by Yu Fu (16582)

Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for lymphoma, multiple myeloma, and other hematological neoplasms in mainland China. by Yu Fu (16582)